期刊文献+

Impact of simultaneous assay, the PCNA, cyclinDl, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system 被引量:17

Impact of simultaneous assay, the PCNA, cyclinDl, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system
下载PDF
导出
摘要 AIM: The aim of the present study is to use immunohistochemical methods to investigate the clinical implications of tumor markers in esophageal squamous cell carcinoma and evaluate their impact on prognosis.METHODS: From November 1990 to December 1996, 47patients were treated with preoperative radiation followed by radical esophagectomy. All patients were confirmed pathologically as suffering from squamous cell carcinoma.Immunohistochemical stain was done for PCNA, cyclinD1 protein expression and DNA content analyzed by image cytometry. Kaplan-Meier method for single prognostic factor and log-rank test was used to test the significant difference. Cox stepwise regression model and prognosis index model were used for survival analysis with multiple prognostic factors.RESULTS: Radio-pathological change, T stage and N stage, as the traditional prognostic factors had statistical difference in 3-, 5- and 10-year survival rates. While, tumor cell proliferating marked PCNA, cyclinD1 and DNA content served as independent prognostic factors of esophageal carcinoma. There was definitely an identity between the single and multiple factor analyses. PI was more accurate to evaluate the prognosis of esophageal carcinoma.CONCLUSION: It is possible that tumor cell proliferating marked PCNA, cyclinD1 and DNA content would become the endpoints for evaluating the prognosis of esophageal carcinoma. AIM: The aim of the present study is to use immunohisto chemical methods to investigate the clinical implications of tumor markers in esophageal squamous cell carcinoma and evaluate their impact on prognosis. METHODS: From November 1990 to December 1996, 47 patients were treated with preoperative radiation followed by radical esophagectomy. All patients were confirmed pathologically as suffering from squamous cell carcinoma. Immunohistochemical stain was done for PCNA, cyclinDl protein expression and DNA content analyzed by image cytometry. Kaplan-Meier method for single prognostic factor and log-rank test was used to test the significant difference. Cox stepwise regression model and prognosis index model were used for survival analysis with multiple prognostic factors. RESULTS: Radio-pathological change, T stage and N stage, as the traditional prognostic factors had statistical difference in 3-, 5- and 10-year survival rates. While, tumor cell proliferating marked PCNA, cyclinDl and DNA content served as independent prognostic factors of esophageal carcinoma. There was definitely an identity between the single and multiple factor analyses. PI was more accurate to evaluate the prognosis of esophageal carcinoma. CONCLUSION: It is possible that tumor cell proliferating marked PCNA, cyclinD1 and DNA content would become the endpoints for evaluating the prognosis of esophageal carcinoma.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第25期3823-3829,共7页 世界胃肠病学杂志(英文版)
基金 Supported by the Distinguished Young Teacher Programs Foundation of Ministry of Education of China, No. 2001125
关键词 PCNA 免疫组织化学 术前 手术治疗 食管癌 放射疗法 Esophageal carcinoma Radiotherapy Cell proliferating marker
  • 相关文献

参考文献2

二级参考文献13

  • 1IsobeH,MiyamotoH,ShimizuT,etal.PrognosticandtherapeuticsignificanceoftheflowcytometricnuclearDNAcontentinnon-smallcellcarcinoma犤J犦[].Cancer.1990
  • 2JunMa,HaiqiangMai,MinghuangHong,etal.Resultsofaprospectiverandomizedtrialcomparingneoadjuvantchemotherapyplusradiotherapywithradiotherapyaloneinpatientswithlocoregionallyadvancednasopharyngealcarcinoma犤J犦[].JClinOncol.2001
  • 3Al-SarrafM,LeBlancM,GiriPGetal.Chemoradiotherapversusradiotherapyinpatientswithadvancednasopharyngealcancer:PhaseIIIrandomizedintergroupStudy0099犤J犦[].JClinOncol.1998
  • 4LutgensLCHW,SchutteB,JongJMA,etal.DNAcontentasprognosticfactorincervixcarcinomastageIB-IIItreatedwithradiotherapy犤J犦[].Gynecologic Oncology.1994
  • 5MerkelDE,DresslerLG,McGuireWL.Flow-cytometrycellularDNAcontentandprognosisinhumanmalignancy犤J犦[].JClinOncol.1987
  • 6EnsleyJF,MaciorowskiZ.ClinicalapplicationsofDNAcontentparametersinpatientswithsquamouscellcarcinomasoftheheadandneck犤J犦[].Seminars in Oncology.1994
  • 7JonesDJ,MooreM,SchofiedPF,etal.RefiningtheprognosticsignificanceofDNAploidystatusincolorectalcancer:aprospectiveflowcytometricstudy犤J犦[].International Journal of Cancer.1988
  • 8HedleyDW,FriendlanderML,TaylorIWetal.MethodforanalysisofcellularDNAcontentofparaffin-embeddedpathologicalmaterialusingflowcytometry犤J犦[].Journal of Histochemistry and Cytochemistry.1983
  • 9KaplanEL,MeierP.Nonparametricestimationfromincompleteobservations犤J犦[].JAmStatAssoc.1958
  • 10CostelloF,MasonBR,CollinsRJ,etal.Aclinicalandflowcytometricanalysisofpatientswithnasopharyngealcancer犤J犦[].Cancer.1990

共引文献15

同被引文献90

引证文献17

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部